Biorem Inc (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 82 | 119 | 59 | 92 | 81 |
| Income taxes - deferred | -196 | -204 | 274 | 49 | -35 |
| Accounts receivable | 3,741 | -944 | -1,217 | 484 | -46 |
| Accounts payable and accrued liabilities | -1,501 | 199 | 2,403 | -1,724 | -135 |
| Other Working Capital | 1,565 | 1,932 | -2,824 | 631 | -475 |
| Other Operating Activity | -2,695 | 1,604 | -388 | 1,420 | 89 |
| Operating Cash Flow | $997 | $2,707 | $-1,693 | $952 | $-521 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -68 | -60 | -44 | -82 | -17 |
| Investing Cash Flow | $-68 | $-60 | $-44 | $-82 | $-17 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 180 | N/A | N/A | N/A | N/A |
| Debt Repayment | -172 | -199 | -397 | 145 | -503 |
| Common Stock Issued | N/A | N/A | 2 | N/A | N/A |
| Other Financing Activity | 69 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $77 | $-199 | $-395 | $145 | $-503 |
| Exchange Rate Effect | -84 | -2,241 | 1,401 | -300 | 154 |
| Beginning Cash Position | 3,775 | 3,568 | 4,298 | 3,584 | 4,471 |
| End Cash Position | 4,696 | 3,775 | 3,568 | 4,298 | 3,584 |
| Net Cash Flow | $1,005 | $2,448 | $-2,132 | $1,015 | $-1,042 |
| Free Cash Flow | |||||
| Operating Cash Flow | 997 | 2,707 | -1,693 | 952 | -521 |
| Capital Expenditure | -68 | -60 | -44 | -82 | -17 |
| Free Cash Flow | 928 | 2,647 | -1,737 | 870 | -538 |